Sunny Bang, MD
Pain Medicine · Loma Linda, CANPI 1225692874
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (49.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 44.2% of the total. Reporting peaked in 2022 at $4,756 and has fallen 97.4% since, to $122 in 2025.
Across 50 payments — averaging $159.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$2K
- Boston Scientific$1K
- Painteq LLC$191
- Saluda Medical Americas, Inc.$137
- Sobi, Inc$125
- plus $369 from 8 others
What the payments were for
- Grants$3,90049%
- Travel & lodging$1,59020%
- Food & beverage$2,46531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $3,515 |
| Abbott | 5 | $2,160 |
| Boston Scientific | 16 | $1,456 |
| Painteq LLC | 4 | $191 |
| Saluda Medical Americas, Inc. | 1 | $137 |
| Sobi, Inc | 1 | $125 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $125 |
| Seagen Inc. | 1 | $121 |
| SPR Therapeutics, Inc | 1 | $25 |
| Globus Medical | 1 | $25 |
| Curonix LLC | 1 | $25 |
| Nevro Corp. | 1 | $22 |
| Electronic Waveform Lab, Inc. | 1 | $15 |
| Vertos Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$2,000
- INTELLIS ADAPTIVESTIM$1,074
- Superion Indirect Decompression System$361
- WaveWriter Alpha Prime 16$255
- KYPHON EXPRESS II KYPHOPAK TRAY$153
- Evoke SCS$137
- Gamifant$125
- PAINTEQ$125
- IMBRUVICA$125
- ADCETRIS$121
- PROCLAIM$117
How this compares
$7,955 in reported general payments places this provider in the 75th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 59 | $3,887 |
| Gabapentin | 227 | $3,269 |
| Diclofenac Sodium | 60 | $3,128 |
| Lidocaine | 65 | $2,948 |
| Duloxetine Hcl | 133 | $2,676 |
| Pregabalin | 85 | $1,860 |
| Methocarbamol | 106 | $1,590 |
| Tizanidine Hcl | 70 | $876 |
| Baclofen | 52 | $689 |
| Naproxen | 55 | $357 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $353 |
| Ondansetron OdtOndansetron | 11 | $276 |
| Ibuprofen | 44 | $259 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $141 |
| Cephalexin | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Loma Linda
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
- Einar OttestadStanford$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.